In recent years a growth inhibitory role in skin for the Rel/NF-kB transcription factors has been established, and the block of Rel/NF-kB signaling results in rapid development of spontaneous skin cancer. The molecular mechanism underlying tumor development is however unknown. In the present study, we show that inhibition of NF-kB signaling in mouse skin by targeted expression of degradation resistant IkB-a generates transgenic keratinocytes unable to arrest the cell cycle in response to DNA damage induced by g-radiation. The results indicate that transgenic keratinocytes have a defect at the G1-S checkpoint whereas the G2-M checkpoint response was found to be intact. However, transgenic keratinocytes still respond by induction of the cyclin dependent kinase inhibitor p21
Introduction
The Rel/NF-kB transcription factors are involved in the regulation of many cellular functions such as cell growth and differentiation, inflammation and immune response, apoptosis, and neoplastic transformation. They are activated by a wide array of stimuli including cytokines, radiation, DNA-damaging agents and cellular stress (Pahl, 1999) . In non-stimulated cells, Rel/NF-kB proteins are retained in the cytoplasm by members of a family of inhibitory IkB proteins. Upon stimulation, IkB is rapidly phosphorylated and degraded allowing Rel/NF-kB to translocate to the nucleus (Karin and Ben-Neriah, 2000) .
A role for NF-kB in skin physiology has been established in the past few years. Specifically, involvement in growth inhibition has been demonstrated in mouse and human skin. Mice overexpressing a constitutively stable form of IkB-a in the skin development epidermal hyperplasia whereas mice expressing a constitutively nuclear form of p50 showed hypoplasia (Seitz et al., 1998) . Providing a link to skin carcogenesis, we have previously shown that inhibition of NF-kB signaling in mouse skin results in the development of squamous cell carcinomas (SCC) (van Hogerlinden et al., 1999) . Furthermore, loss of function studies of IKKa, a subunit of the IkB kinase complex, similarly showed epidermal hyperplasia, this time accompanied by defects in terminal differentiation (Hu et al., 1999 (Hu et al., , 2001 Li et al., 1999; Takeda et al., 1999) .
Female mice, heterozygous for IKKg deficiency, the regulatory subunit of the kinase complex, develop a skin phenotype similar to the human x-linked disorder incontinentia pigmenti (IP) (Makris et al., 2000; Schmidt-Supprian et al., 2000) . Moreover, it was recently shown that most cases of IP are due to muations in the IKKg gene (Smahi et al., 2000) . In addition, x-linked anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) is caused by impaired NF-kB signaling due to mutations in IKK-g (Doffinger et al., 2001; Zonana et al., 2000) .
Epidermis, the outermost part of the skin, consists of stratified squamous epithelium. Keratinocytes multiply in the basal layer and migrate to the surface, terminally differentiating at the same time and forming keratinized squames that are eventually shed. In this process, the differentiating cell is withdrawn from the cell cycle.
In this scenario, NF-kB, which resides in the cytoplasm in its inactive state in basal cells, is activated and migrates to the nucleus in terminally differentiating cells (Seitz et al., 1998) . It is therefore plausible to assume that activation of NF-kB can regulate some of the cell cycle components responsible for cell cycle arrest. Indeed, a recent study shows that NF-kB subunits induce growth arrest in epithelial cells in association with the selective induction of the cyclindependent kinase inhibitor p21
Cip1/Waf (Seitz et al., 2000) .
The rapid cancer development in mouse skin overexpressing constitutively stable IkB-a seen in our previous study indicates that inhibition of NF-kB disrupts epidermal cell homeostasis and overrides the cell cycle arrest signals.
In this study we show that inhibition of NF-kB leads to increased proliferation and defective DNA damageinduced cell cycle arrest in vivo, and that the resulting tumors are aneuploid but independent of mutations in the Ha-ras or p53 genes.
Results

High proliferation rate in transgenic skin and tumors
The skin histology and carcinoma formation observed in our previous study using transgenic mice overexpressing constitutively stable IkB-a in the epidermis (van Hogerlinden et al., 1999) , suggested that keratinocyte proliferation was increased. One of the features of neoplastic progression is inappropriate and increased frequency of proliferating cells. To determine the rate of proliferation in transgenic skin and tumors we examined the expression of Ki-67, a nuclear protein expressed by proliferating cells (Schluter et al., 1993) . Few Ki-67 positive cells were seen in the epidermis of nontransgenic mice. In transgenic skin an increased number of Ki-67 positive cells was observed in the epidermis and Ki-67 expression was also observed in suprabasal layers (Figure 1 ). In the transgenic tumors, which comprised of well differentiated squamous cell carcinomas, there was strong, widespread expression of Ki-67 (data not shown).
We also performed BrdU incorporation analysis to examine DNA synthesis directly in the epidermis. Tail skin biopsies were taken from 8-day-old transgenic and littermate control mice 1 h after injection of BrdU. Immunohistochemical analysis showed an increased BrdU-labeling in transgenic epidermis (35+3.8% vs 23+1.1% of interfollicular basal cells, Student's t-test, n=4 mice/group, P50.01) and the appearance of BrdUpositive cells in suprabasal layers (Figure 4a ). The results demonstrate an increased proliferation rate in transgenic epidermal cells and tumors consistent with a proposed growth inhibitory function of NF-kB in epidermis.
Increased expression of cell cycle target genes in transgenic mice skin tumors
The growth inhibiting function of NF-kB in epidermis might be dependent on regulation of cell cycle components. NF-kB has been shown to regulate the expression of several cell cycle proteins including p53, p21
Cip1/Waf and cyclin D (Bash et al., 1997; Hinz et al., 1999; Webster and Perkins, 1999) . p53 mutations are frequently found in SCCs of the skin and cyclin D and p21 Cip1/Waf have been shown to be overexpressed in SCC (Ahmed et al., 1997; Inohara et al., 1996; Matsuta et al., 1997; Mitsunaga et al., 1995; Robles and Conti, 1995; Tron et al., 1996) . To examine if expression of these proteins was altered in transgenic squamous cell carcinomas we used immunohistochemical analysis. Expression of these proteins is normally not observed in adult mouse skin using immunohistochemistry. Strong nuclear expression of p21
Cip1/Waf was observed in transgenic tumor cells which is also seen in human SCCs (Figure 2a ) (Ahmed et al., 1997; Matsuta et al., 1997; Tron et al., 1996) . However, we also observed a different staining pattern in 30% of the tumors (total n=10), where expression was seen in the cytoplasm of highly differentiated cells (Figure 2b ). Forty per cent of the tumors showed both expression patterns (Figure 2c) .
Cyclin D was expressed in transgenic tumors, although the expression was low in 50% of the tumors examined ( Figure 2d ). Expression of cyclin D has been observed in human SCCs and also in mouse skin tumors generated by a two-stage carcinogenesis proteocol (Inohara et al., 1996; Mitsunaga et al., 1995; Robles and Conti, 1995) . No detectable expression of cyclin D (the antibody recognizes cyclins D1 and D2) was observed in non-tumor transgenic skin or in normal mouse skin (data not shown).
Immunohistochemical staining for p53 revealed an increased, scattered expression in transgenic tumors ( Figure 2e ). This is in concordance with the increased expression of p53 seen in DMBA/TPA-or UV-induced mouse skin tumors and in human SCCs (McGregor et al, 1992; Mitsunaga et al., 1995; Ren et al., 1996b; Ro et al., 1993; Tong et al., 1997) . This increase is considered to be a response to DNA damage or mutations in the p53 gene. No increased p53 expression was observed in morphologically unaffected skin (data not shown).
Wild-type p53 and Ha-ras in transgenic skin tumors Since Ha-ras and p53 mutations are frequently found in mouse and human non-melanoma skin tumors (Brash et al., 1991; Pierceall et al., 1991; Ren et al., 1996a; Tong et al., 1997) , we decided to examine if such mutations were present in transgenic tumors. The increased expression of p53 seen in transgenic tumors suggested a possible role for p53 in the development of these tumors. However, mutation analysis of p53 exons 5 -8 using PCR amplification and direct sequencing of tumor DNA (n=8) did not reveal any mutations (Table 1) . This finding suggests that inhibition of NF-kB in epidermis is sufficient to drive tumor formation independent of mutations in the p53 gene. Mutations in genes belonging to the ras family are additionally observed in human non-melanoma skin cancers. In human SCCs of the skin the Ha-ras gene shows the highest mutation frequency (Pierceall et al., 1991) , and in the mouse skin multistage carcinogenesis (DMBA/ TPA) model, a mutation at codon 61 of the Ha-ras gene is considered to be the initiating event (Quintanilla et al., 1986) . However, mutation analysis of exons 1 and 2 of the Ha-ras gene including the hot spot regions codons 12, 13 and 61 did not reveal any mutations (Table 1) . As a control, DMBA/TPA incuded skin tumors from wildtype mice were included. An A?T mutation in codon 61 was detected in all control tumors (n=4). The results indicate that inhibition of NF-kB can induce skin tumor development independently of a mutation in the Ha-ras gene as an initiating event or later p53 mutations and that IkB-a is a candidate oncogene. High proliferation rate in transgenic skin. The proliferation rate was examined in transgenic (b) and wild-type skin (a) using an antibody detecting Ki-67. Skin samples from 2-week-old transgenic mice or control littermates were sectioned and immunostained using a polyclonal Ki-67 antibody. Bar=100 mm
Aneuploidy in transgenic tumors
Genomic instability is known to be a hallmark of multistage carcinogenesis (Coleman and Tsongalis, 1995; Hanahan and Weinberg, 2000) and we further wanted to investigate if inhibition of Rel/NF-kB signaling can lead to genomic instability, perhaps by perturbation of cell cycle regulation. For the purpose, we examined the DNA-content in transgenic skin and tumor cells using a method that quantifies DNAcontent in paraffin-embedded material using image analysis. Aneuploidy was observed in transgenic tumors (n=3) but not in unaffected transgenic skin (Figure 3 and data not shown), supporting the notion that these tumors are genetically unstable.
Transgenic keratinocytes are unable to arrest the cell cycle in response to DNA damage
The cell cycle checkpoint control serves to prevent cells with damaged DNA from either replicating (G1-S and S phase checkpoint) or dividing (G2-M checkpoint). The high proliferation rate, aneuploidy and cancer development in transgenic skin suggest that defects in cell cycle control are present. To address this, we irradiated transgenic and littermate control mice with 5 Gray of g-radiation. Mice were injected with BrdU 1 h before sacrifice and a BrdUlabeling analysis was performed on tail skin samples. Tail skin was used since the cancer development frequently occurred at this site. Results show a 60% reduction of S phase cells in wild-type keratinocytes 24 h after irradiation. Transgenic keratinocytes however, show an almost complete inability to block S phase entry after DNA-damage (Figure 4a,b) . These results indicate that transgenic keratinocytes have a defect at the G1-S checkpoint which allows cells with damaged DNA to enter the S phase.
Using morphological criteria or staining with an antibody recognizing active caspase 3 we were unable to detect an enhanced rate of apoptosis in interfollicular epidermis following irradiation suggesting that non-arrested cells are not subsequently eliminated by apoptosis (data not shown).
To examine if the G2-M checkpoint is functional in transgenic skin we used immunohistochemical analysis to stain cells expressing phospho-Histone H3, which is a marker for mitotic cells (Hendzel et al., 1997) . The mitotic index was scored at different timepoints after radiation. Unirradiated transgenic skin displayed a higher mitotic index compared to wild-type skin (35+4.2 vs 11+3.0 mitotic cells/20 h.p.f., Student's t-test, n=4 mice/group, P50.001). However, both wild-type and transgenic keratinocytes displayed a sharp reduction in mitotic index 4 h after radiation (Figure 4c) , indicating that the G2-M checkpoint is intact in transgenic keratinocytes following g-radiation.
Taken together the data support the hypothesis that in epidermal cells NF-kB signaling is an important determination of the DNA-damage response. As a control, DMBA/TPA-induced skin tumors from wild-type mice were included, and A?T mutation in codon 61 was detected in all control tumors. wt, wild-type; nd, not done were quantitated by counting BrdU-positive cells in 500 cells of interfollicular epidermis of each skin section, and sections from four mice per genotype at each time point were examined. Eight-day-old mice were irradiated with ionizing radiation or left untreated and were sacrificed 24 h later. BrdU was injected i.p. 1 h before sacrifice. Tail-skin samples were sectioned and immunostained with an antibody detecting BrdU. (c) Normal mitotic delay in transgenic keratinocytes. Mitotic cells were stained using an antibody detecting phospho-Histone H3. The mitotic index was scored at different time points after radiation. Both wild-type and transgenic keratinocytes displayed a sharp reduction in mitotic index 4 h after radiation. To quantitate the number of mitotic cells, phospho-Histone H3 positive cells were counted in 20 randomly selected high power fields (4006 magnification) of each skin section, and sections from four mice per genotype at each time point were examined. wt, wild-type; tg, transgenic. Error bars represent standard deviation. Statistical analysis was performed using the Student's t-test. *P50.05
Inability to arrest after DNA damage is independent of p21 induction
The cell cycle arrest at the G1-S transition in response to DNA damage is considered to be p53 dependent (Amundson et al., 1998) and achieved by upregulation of p21
Cip1/Waf , a cyclin dependent kinase (cdk) inhibitor. To examine the role of p21 Cip1/Waf in the DNA damage response in transgenic keratinocytes, we performed immunohistochemical analyis using an antip21
Cip1/Waf antibody. The expression of p21 Cip1/Waf is upregulated in a similar manner 24 h following g-radiation in both wildtype and transgenic cells ( Figure 5 ) which leads us to the conclusion that the ability of transgenic keratinocytes to block S phase entry is not due to lack of p21 Cip1/Waf accumulation.
Discussion
In this study, we have shown that inhibition of Rel/ NF-kB in skin leads to a defect in DNA damageinduced cell cycle arrest, associated with development of genetically unstable tumors. We observed an increased expression of the cyclin dependent kinase (Cdk) inhibitor p21 Cip1/Waf in transgenic tumors. This is consistent with observations in human SCCs (Ahmed et al., 1997; Matsuta et al., 1997; Tron et al., 1996) . The function of p21 Cip1/Waf is to inhibit Cdk-2 from phosphorylating Rb which in turn prevents activation of downstream targets and leads to cell cycle arrest. This mechanism is believed to be dependent on the induction of p21
Cip1/Waf by wild-type p53 following
Cip1/Waf induction mechanisms clearly exist. The observation that p21
Cip1/Waf is upregulated in human SCCs is somewhat surprising, but may be explained as an attempt to stop proliferation of tumor cells. Furthermore, p21 7/7 mice do not develop tumors spontaneously but are more susceptible to chemicalinduced tumorigenesis (Topley et al., 1999; Weinberg et al., 1999) . The upregulation of p21 Cip1/Waf seen in transgenic tumors with inhibited NF-kB signaling contrasts with a recent study which showed that NFkB-triggered cell cycle arrest in epithelial cells is associated with selective induction of p21 Cip1/Waf (Seitz et al., 2000) , but may be a secondary effect due to induction by increased p53 expression.
Besides the p21 Cip1/Waf nuclear staining pattern previously reported in human cancers we also observed a different staining pattern, with cytoplasmic staining of differentiated cells. Poon and Hunter (1998) have previously observed a short form of p21, present in UV-treated or transformed cells, which was present mainly in the cytoplasm. Moreover, a recent study shows cytoplasmic localization of p21
Cip1/Waf in HER-2/neu overexpressing cells and breast tumors due to phosphorylation by Akt, which also leads to suppression of growth inhibition (Zhou et al., 2001) . At present we do not know if the cytoplasmic p21
Cip1/Waf represents a variant or modified p21
Cip1/Waf protein. Overexpression of cyclin D has also been observed in both human and mouse skin tumors (Inohara et al., 1996; Mitsunaga et al., 1995; Robles and Conti, 1995) . Transgenic mice overexpressing cyclin D1 in the skin develop hyperplasia but no skin tumors (Robles et al., Figure 5 Normal p21 induction in transgenic keratinocytes following radiation. Eight-day-old mice were irradiated with ionizing radiation (5 Gy) or left untreated and were sacrificed 24 h later. Tail skin sections from transgenic mice (c,d) or wild-type littermates (a,b) were stained using an anti-p21 antibody. For each time point and genotype, four mice were studied. Bar=100 mm 1996). Cyclin D1-deficient mice, however, show reduced skin tumor development (Robles et al., 1998) , suggesting that cyclin D1 expression enhances tumor development but alone is insufficient to initiate tumor development. Thus, the observed increased cyclin D expression in the tumor cells is not likely to be the driving force behind tumor development in the IkB-a transgenic mice.
We observed an increased expression of p53 in transgenic tumors, suggesting an involvement of p53 in the development of these tumors. However, mutation analysis of exons 5 -8 of p53 did not reveal any mutations, suggesting that inhibition of NF-kB in epidermis is sufficient to drive tumor formation independent of mutations in the p53 gene and that p53 expression is more likely due to presence of damaged DNA in some cells. Consistent with this idea, p53 expression was scattered and not present in all tumor cells. Moreover, mutation analysis of exons 1 -2 of the Ha-ras gene did not reveal any mutations.
These results suggest that inhibition of NF-kB can induce tumorigenesis in mouse skin independently of a mutation in the Ha-ras gene as an initiating event. This is in contrast to the very high frequency of Ha-ras mutations in tumors induced in mouse skin by DMBA/ TPA. However, several studies indicate that Ha-ras mutations are a rare event in human SCCs and UVinduced murine tumors (Campbell et al., 1993; Rumsby et al., 1990; Sutter et al., 1993; van der Schroeff et al., 1990) demonstrating the existence of alternative initiating genetic alterations.
Given the very rapid cancer development seen in the transgenic mice we considered the possibility that inhibition of Rel/NF-kB signaling can lead to genomic instability, perhaps by perturbation of cell cycle regulation. An examination of DNA content in transgenic tumor cells revealed a high degree of aneuploidy, supporting this hypothesis. However, at present we cannot exclude the possibility that the observed aneuploidy is an indirect late effect rather than associated with the early stages of tumor formation.
To directly test the effect of Rel/NF-kB inhibition on cell cycle regulation after DNA damage, we examined the integrity of cell cycle checkpoints by exposing mice to g-radiation. The results were very surprising and clear. Transgenic keratinocytes are unable to arrest the cell cycle in response to DNA damage induced by gradiation. Whereas the G2-M checkpoint causing a transient mitotic delay appeared unaffected, the fraction of S phase cells was essentially the same in non-irradiated and irradiated transgenic skin pointing towards a defect in the G1-S or S phase checkpoints.
It is believed that the cell cycle arrest following DNA damage is p53-dependent and requires p21 Cip1/Waf induction (Amundson et al., 1998) . Although transgenic keratinocytes were unable to arrest, the induction of p21
Cip1/Waf following radiation was completely normal. A recent study showed that NF-kB-triggered cell cycle arrest in epithelial cells in vitro is associated with the selective induction of p21
Cip1/Waf (Seitz et al., 2000) . An active NF-kB subunit expressed in the epidermis of p21 7/7 mice, however, still displayed significant growth-inhibitory effects, suggesting that NF-kB dependent growth inhibition is only partially p21
Cip1/Waf dependent (Seitz et al., 2000) . Interestingly, similar exposure of p21 7/7 mice to g-radiation showed an essentially complete loss of growth arrest (Song and Lambert, 1999) , indicating that in vivo p21 Cip1/Waf is required for radiation-induced growth arrest. Since, at least in vitro, overexpression of p21 Cip1/Waf is sufficient to induce growth arrest (Seitz et al., 2000) , we consider it likely that NF-kB signaling targets a step downstream of p21
Cip1/Waf induction. However, an effect on p21 post-translational modification making the p21 protein less active remains a possibility. Alternatively, the abundant p21 protein could be sequestered by cyclin D/CDK complexes. The assembly of cyclin D/ CDK complexes has been shown to require p21 with the resulting complexes being catalytically active and not inhibited by the p21 interaction. Furthermore, such sequestration by cyclin D/CDK would free p21 from cyclin E/CDK2 complexes which thus become available to drive G1-S progression (Sherr and Roberts, 1999) . It should however be noted that by immunohistochemistry, no detectable cyclin D expression was observed in unaffected transgenic or normal mouse epidermis.
Another possible mechanism could be that transgenic keratinocytes do not fail to arrest at the G1-S transition but instead show a defect in the S phase checkpoint control. Activation of the S phase DNA damage checkpoint results in a transient reduction in the rate of DNA synthesis (Bartek and Lukas, 2001; Larner et al., 1994) . In this scenario, the normal p21 accumulation observed could reflect a functional G1-S checkpoint and the observed lack of arrest would be due to a defect in the S phase DNA damage checkpoint. However, previous studies show that the radiation-induced inhibition of DNA replication lasts only a few hours (Larner et al., 1994; Xie et al., 1998) , suggesting that this is an unlikely mechanism in this case, since in non-transgenic mice the number of S phase cells is significantly reduced at 24 h whereas no such reduction is observed in the IkB-a transgenic mice. Based on the above reasoning we conclude that in epidermal cells with blocked NF-kB signaling the G1-S cell cycle checkpoint is compromised at the level of p21
Cip1/Waf or downstream. Interestingly, two studies have shown the association of Cdk2/cyclin E with NF-kB, in one case in cells at the G1-S phase transition (Chen and Li, 1998; Perkins et al., 1997) .
An important question is how inhibition of NF-kB can lead to cancer development. Considering the unique role of NF-kB in skin, inhibition of NF-kB signaling results in an increased proliferation of epidermal keratinocytes which combined with an inability to arrest following DNA damage may lead to the accumulation of chromosomal damage and genomic instability. Interestingly, development of keratoacanthomas and subungual keratotic tumors are observed in patients suffering from incontinentia pigmenti, a syndrome caused by mutations in IKKg leading to a block of NF-kB signaling (Korstanje and Bessems, 1991; Landy and Donnai, 1993; Sakai et al., 2000) .
In summary, our data demonstrate that inhibition of Rel/NF-kB in skin results in a defect in cell cycle arrest at G1-S, an increased proliferation rate and the development of aneuploid skin tumors. Furthermore, the lack of mutations in Ha-ras or p53 suggest a Rasand p53-independent mechanism of skin tumor development.
Materials and methods
Transgenic mice
The K5-IkB-a transgenic mice were generated as described previously (van Hogerlinden et al., 1999) .
Immunohistochemical staining
Skin biopsies were fixed overnight in 4% paraformaldehyde and paraffin embedded. Sections were deparaffinized in xylene, passed through a graded alcohol series and then microwaved for 10 min in 10 mM sodium citrate buffer (pH 6.0). After rinsing in H 2 O, sections were incubated in 0.3% H 2 O 2 in methanol to block endogenous peroxidase activity. Sections were washed in PBS and blocked in 5% goat serum in PBS. Sections were incubated with primary antibody in PBS containing 2% goat serum for 1 h at room temperature or overnight at 48C. After washing in PBS, sections were incubated with biotinylated secondary antibody (Vector Laboratories) in PBS, washed in PBS and incubated with streptavidin peroxidase (Zymed). The sections were washed in PBS and visualized using AEC or DAB substrate kit (Zymed). Sections were counterstained with hematoxylin. Primary antibodies used were: rabbit polyclonal anti-Cyclin D (Upstate Biotechnology) 1 : 200, rabbit polyclonal anti-p53 (Novocastra) 1 : 700, rabbit polyclonal anti-Ki67 (Novocastra) 1 : 700, rabbit polyclonal anti-phospho Histone H3 (Upstate Biotechnology) 1 : 750. Detection of p21
Cip1/Waf was per-formed using a mouse monoclonal antibody (Santa Cruz Biotechnology) diluted 1 : 25 and the Histomouse kit (Zymed) according to the manufacturer's instructions. As negative controls, all experiments were also performed in the presence of equal concentrations of normal rabbit or mouse IgG.
Mutation analysis
Microdissection of 10-mm paraffin sections was performed, and normal cells were separated from tumor cells using a scalpel. Microdissected tissue was incubated in digestion buffer (10 mM KCl, 1.5 mM MgCl 2 , 10 mM Tris, pH 9.0, 0.5% Tween 20) containing 200 mg/ml proteinase K at 558C for 6 h. Amplification of exons 5 -8 of the mouse p53 gene or exons 1 and 2 of the mouse Ha-ras gene was performed as follows: 10 ml aliquots of tumor lysate were used for PCR amplification in a 20-ml reaction volume containing 2 ml 106reaction buffer without MgCl 2 (Promega); 250 mM of each dNTP; 3.2 pmol of each primer; and 0.5 units Taq polymerase (Promega). The primers used for amplification of the murine p53 or Ha-ras exons and the individual MgCl 2 concentrations have previously been described (Devereux et al., 1993; Hegi et al., 1993) . Thirty-five cycles of amplification were carried out, with denaturation at 948C for 1 min, annealing at 54 or 588C (p53, dependent on the exon), or 608C (Ha-ras) for 2 min, and extension at 728C for 2 min. PCR products were purified by using Microspin columns (Amersham Pharmacia Biotech) and subjected to sequencing.
DNA-content analysis
Image cytometric analysis was performed on Feulgen-stained histological sections, 4 and 8 mm thick, to investigate the nuclear DNA content. The staining procedure, internal standardization and tumor cell selection were based on methods described earlier (Auer et al., 1994) . All of the DNA values were expressed in relation to the corresponding staining controls, which were given the value 2c, denoting the normal diploid DNA content.
Irradiation and BrdU-labeling
Eight-day-old transgenic mice or control littermates were irradiated with 5 Gray (Gy) of g-rays using a 137 Cs source. Mice were sacrificed at 4, 24, 48 h or 14 days after irradiation. Unirradiated mice were used as controls. For each time point and genotype, four mice were studied. One hour before sacrifice, mice were injected i.p. with 100 mg/g body weight of 5-bromo-2'-deoxyuridine (BrdU, Sigma). Tail skin biopsies were fixed in 4% paraformaldehyde and paraffin embedded. BrdU-incorporation was detected using the BrdU staining kit (Oncogene Research Products) according to the manufacturer's instructions. The number of BrdU-positive cells were counted in 500 cells of interfollicular epidermis of each skin section, and sections from four mice per genotype at each time point were examined. To quantitate the number of mitotic cells, phospho-Histone H3 positive cells were counted in 20 randomly selected high power fields (4006 magnification) of each skin section, and sections from four mice per genotype at each time point were examined.
